Medicalgorithmics SA (MDG) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Synektik SA

Biomaxima SA

PZ Cormay SA

Zortrax SA

Medicalgorithmics SA

Scope Fluidics SA

Medinice SA

Airway Medix SA

Milestone Medical, Inc.

Grupa Modne Zakupy SA

Milton Essex SA

Why is Medicalgorithmics SA ?

Poor Management Efficiency with a low ROE of 0%

The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Net Sales has grown by an annual rate of -26.13% and Operating profit at 9.04% over the last 5 years

The company has declared Negative results for the last 6 consecutive quarters

NET SALES(HY) At PLN 12.63 MM has Grown at -35.39%
INTEREST(HY) At PLN 0.33 MM has Grown at 1,377.27%
NET PROFIT(HY) At PLN -8.83 MM has Grown at -70.21%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 90.83%, its profits have fallen by -23.5%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Medicalgorithmics SA for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Medicalgorithmics SA

92.44%

0.61

48.02%

Poland WIG

39.24%

1.84

20.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-26.13%

EBIT Growth (5y)

9.04%

EBIT to Interest (avg)

-17.34

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.03

Sales to Capital Employed (avg)

0.38

Tax Ratio

1.91%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.26%

ROCE (avg)

0.27%

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.85

EV to EBIT

-20.83

EV to EBITDA

-23.65

EV to Capital Employed

4.25

EV to Sales

14.13

PEG Ratio

Dividend Yield

ROCE (Latest)

-20.41%

ROE (Latest)

-19.29%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at PLN -8.83 MM

RAW MATERIAL COST(Y)

Fallen by -3.68% (YoY

OPERATING PROFIT(Q)

Highest at PLN -3.58 MM

OPERATING PROFIT MARGIN(Q)

Highest at -52.9 %

-25What is not working for the Company

NET SALES(HY)

At PLN 12.63 MM has Grown at -35.39%

INTEREST(HY)

At PLN 0.33 MM has Grown at 1,377.27%

NET PROFIT(HY)

At PLN -8.83 MM has Grown at -70.21%

ROCE(HY)

Lowest at -20.18%

DEBT-EQUITY RATIO (HY)

Highest at 7.85 %

CASH AND EQV(HY)

Lowest at PLN 11.07 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.83%

Here's what is working for Medicalgorithmics SA

Net Profit

Higher at PLN -8.83 MM

than preceding 12 month period ended Mar 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (PLN MM)

Operating Profit

Highest at PLN -3.58 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (PLN MM)

Operating Profit Margin

Highest at -52.9 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Raw Material Cost

Fallen by -3.68% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Medicalgorithmics SA

Net Sales

At PLN 12.63 MM has Grown at -35.39%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (PLN MM)

Interest

At PLN 0.33 MM has Grown at 1,377.27%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (PLN MM)

Net Profit

At PLN -8.83 MM has Grown at -70.21%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (PLN MM)

Debt-Equity Ratio

Highest at 7.85 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at PLN 11.07 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debtors Turnover Ratio

Lowest at 2.83%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio